Hussam Abou-Al-Shaar
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Also affiliated: UPMC Health System (2024); University of Pittsburgh Medical Center (2026); Neurological Surgery (2024–2026); The University of Texas Health Science Center (2026)
Faculty Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Hussam Abou-Al-Shaar's research focuses on neurological disorders and treatments, with recent publications examining the utility of percutaneous injections for refractory trigeminal neuralgia and the management of meningitis through lumbar and external ventricular drainage. His work also investigates the patterns and risk factors associated with meningiomas, particularly those linked to depot medroxyprogesterone acetate (DMPA) use, and explores genomic hallmarks of these tumors. Additionally, Abou-Al-Shaar has published on the comparative effectiveness of surveillance versus stereotactic radiosurgery for vestibular schwannoma in older patients and retrospective analyses of metastasis risk factors in chordomas. He has authored 10 publications, with his most recent work appearing in 2026, indicating recent activity in his research pursuits.
Metrics
- h-index: 1
- Publications: 12
- Citations: 1
Selected Publications
-
Utility of Percutaneous Meckel's Cave Methylprednisolone/Bupivacaine Injection for Patients With Refractory Trigeminal Neuralgia With Concomitant Continuous Pain (2026)
-
Risk Factors for Developing Metastasis in Chordomas: A Retrospective Analysis of 194 Patients (2026)
Collaboration Network
Top Collaborators
- Risk Factors for Developing Metastasis in Chordomas: A Retrospective Analysis of 194 Patients
- Risk Factors for Developing Metastasis in Chordomas: A Retrospective Analysis of 194 Patients
- Risk Factors for Developing Metastasis in Chordomas: A Retrospective Analysis of 194 Patients
- Risk Factors for Developing Metastasis in Chordomas: A Retrospective Analysis of 194 Patients
- Risk Factors for Developing Metastasis in Chordomas: A Retrospective Analysis of 194 Patients
- Risk Factors for Developing Metastasis in Chordomas: A Retrospective Analysis of 194 Patients
- Risk Factors for Developing Metastasis in Chordomas: A Retrospective Analysis of 194 Patients
- Risk Factors for Developing Metastasis in Chordomas: A Retrospective Analysis of 194 Patients
- Risk Factors for Developing Metastasis in Chordomas: A Retrospective Analysis of 194 Patients
- Risk Factors for Developing Metastasis in Chordomas: A Retrospective Analysis of 194 Patients
- Utility of Percutaneous Meckel's Cave Methylprednisolone/Bupivacaine Injection for Patients With Refractory Trigeminal Neuralgia With Concomitant Continuous Pain
- Utility of Percutaneous Meckel's Cave Methylprednisolone/Bupivacaine Injection for Patients With Refractory Trigeminal Neuralgia With Concomitant Continuous Pain
- Utility of Percutaneous Meckel's Cave Methylprednisolone/Bupivacaine Injection for Patients With Refractory Trigeminal Neuralgia With Concomitant Continuous Pain
- Utility of Percutaneous Meckel's Cave Methylprednisolone/Bupivacaine Injection for Patients With Refractory Trigeminal Neuralgia With Concomitant Continuous Pain
- Utility of Percutaneous Meckel's Cave Methylprednisolone/Bupivacaine Injection for Patients With Refractory Trigeminal Neuralgia With Concomitant Continuous Pain
Similar Researchers
Based on overlapping research topics